The percutaneous puncture surgery robot market size has grown rapidly in recent years. It will grow from $1.98 billion in 2025 to $2.23 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to development of robotic surgical platforms, rising demand for minimally invasive procedures, advancements in imaging-guided surgery, increasing prevalence of urological and orthopedic surgeries, awareness of surgical precision benefits.
The percutaneous puncture surgery robot market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to adoption of ai-guided surgical systems, expansion in hospital and ambulatory surgical centers, integration of augmented reality with robotics, innovations in percutaneous puncture procedures, partnerships between robot manufacturers and healthcare providers. Major trends in the forecast period include robotic-assisted percutaneous surgery, augmented reality navigation systems, ai-guided needle placement, minimally invasive surgical robotics, integration with imaging modalities.
The growing preference for minimally invasive procedures is expected to drive the expansion of the percutaneous puncture surgery robot market. These procedures, which are performed through small incisions or openings, minimize patient trauma and shorten recovery times. The demand for such surgeries is rising because they offer quicker recovery, reduced complication risks, less pain, and smaller scars. This makes them an attractive option for patients looking for safer and faster treatments. Percutaneous puncture surgery robots enhance these procedures by offering precise needle guidance, making them particularly effective for tumor ablations and biopsies. By reducing surgical errors and providing real-time navigation, they improve both patient safety and procedural efficiency. For example, a report by the American Society of Plastic Surgeons in June 2024 revealed that minimally invasive procedures increased by 7% in 2023, outpacing traditional surgical methods by 2%. This trend is contributing to the growth of the percutaneous puncture surgery robot market.
Leading players in the percutaneous puncture surgery robot market are developing advanced technologies, such as vascular intervention surgical robots, to improve precision, reduce complications, and accelerate recovery. These robotic systems are specifically designed to assist in performing minimally invasive procedures on blood vessels, offering precise control when navigating catheters and guidewires. For instance, in December 2023, Robocath S.A.S., a French MedTech firm, collaborated with Microport Medical B.V. from China and received approval from the National Medical Products Administration (NMPA) for their R-ONE vascular intervention surgical robot. This robot aids interventional cardiologists in performing accurate, minimally invasive procedures, such as percutaneous coronary interventions (PCI), by enhancing control, improving safety, and minimizing radiation exposure. The robot features advanced dual-finger grasp mimic technology, enabling continuous rotation from 0 to 360 degrees and providing precise, hand-like manipulation for complex vascular lesions. Moreover, it reduces radiation exposure for both patients and operators through optimized robotic navigation and less reliance on fluoroscopy.
In February 2025, Toulouse University Hospital (CHU), located in France, acquired the Epione robotic platform from Quantum Surgical SAS to advance minimally invasive cancer treatments. This acquisition is part of the hospital's commitment to enhancing precision in cancer care and improving patient outcomes using state-of-the-art robotic technology. Quantum Surgical SAS, a French medical robotics company, specializes in percutaneous puncture surgery robots.
Major companies operating in the percutaneous puncture surgery robot market are Intuitive Surgical Inc., Quantum Surgical SAS, iSYS Medizintechnik GmbH, Perfint Healthcare Private Limited, MicroPort Corporation, Robocath S.A.S., XACT Robotics Inc., NDR Medical Technology, Yuanhua Technology Co. Ltd., BEC Medical, Perlove Medical, Biobot Surgical Pte Ltd, Veran Medical Technologies Inc., Clear Guide Medical, Aimooe Technology Co. Ltd., Renishaw plc, Zimmer Biomet Holdings Inc., Perfexion Robotics, NeuroPuncture Systems, Synaptive Medical.
North America was the largest region in the percutaneous puncture surgery robot market in 2025. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the percutaneous puncture surgery robot market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the percutaneous puncture surgery robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the percutaneous puncture surgery robot market by raising import costs for robotic components, imaging systems, and ai software modules. Hospitals, ambulatory surgical centers, and specialized clinics in Europe, North America, and Asia-Pacific are most affected. Segments such as prostate and lung puncture robots, which rely heavily on imported precision components, face increased costs and adoption delays. Positive impacts include encouraging local assembly and software development, boosting innovation in cost-optimized robotic systems, and diversifying supply chains.
The percutaneous puncture surgery robot market research report is one of a series of new reports that provides percutaneous puncture surgery robot market statistics, including percutaneous puncture surgery robot industry global market size, regional shares, competitors with a percutaneous puncture surgery robot market share, detailed percutaneous puncture surgery robot market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous puncture surgery robot industry. This percutaneous puncture surgery robot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A percutaneous puncture surgery robot is a medical robotic system designed to assist surgeons in performing minimally invasive procedures by precisely guiding needles or instruments through the skin to target internal tissues or organs. These robots enhance surgical accuracy, reduce human error, and minimize patient trauma compared to traditional manual puncture techniques.
The primary types of percutaneous puncture surgery robots include prostate puncture robots, lung puncture robots, kidney puncture robots, and pancreas puncture robots. A prostate puncture robot is a specialized system that helps surgeons accurately guide needles or instruments for minimally invasive procedures, such as biopsies or therapies, within the prostate gland. Based on surgical approach, these robots are classified into robot-assisted percutaneous surgery and traditional percutaneous surgery. They integrate advanced technologies such as robotic-assisted navigation, augmented reality, and artificial intelligence and machine learning. Applications span multiple surgical fields, including orthopedic, cardiovascular, neurological, urological, and general surgery, serving end-users such as hospitals, ambulatory surgical centers, and specialized clinics.
The percutaneous puncture surgery robot market consists of revenues earned by entities by providing services such as surgical planning and simulation services, maintenance and technical support, remote surgery and teleoperation support, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous puncture surgery robot market also includes sales of robotic arm systems, 3D imaging and navigation systems, needle insertion modules, endoscopic camera systems, computer-aided planning software, and haptic feedback systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The percutaneous puncture surgery robot market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to adoption of ai-guided surgical systems, expansion in hospital and ambulatory surgical centers, integration of augmented reality with robotics, innovations in percutaneous puncture procedures, partnerships between robot manufacturers and healthcare providers. Major trends in the forecast period include robotic-assisted percutaneous surgery, augmented reality navigation systems, ai-guided needle placement, minimally invasive surgical robotics, integration with imaging modalities.
The growing preference for minimally invasive procedures is expected to drive the expansion of the percutaneous puncture surgery robot market. These procedures, which are performed through small incisions or openings, minimize patient trauma and shorten recovery times. The demand for such surgeries is rising because they offer quicker recovery, reduced complication risks, less pain, and smaller scars. This makes them an attractive option for patients looking for safer and faster treatments. Percutaneous puncture surgery robots enhance these procedures by offering precise needle guidance, making them particularly effective for tumor ablations and biopsies. By reducing surgical errors and providing real-time navigation, they improve both patient safety and procedural efficiency. For example, a report by the American Society of Plastic Surgeons in June 2024 revealed that minimally invasive procedures increased by 7% in 2023, outpacing traditional surgical methods by 2%. This trend is contributing to the growth of the percutaneous puncture surgery robot market.
Leading players in the percutaneous puncture surgery robot market are developing advanced technologies, such as vascular intervention surgical robots, to improve precision, reduce complications, and accelerate recovery. These robotic systems are specifically designed to assist in performing minimally invasive procedures on blood vessels, offering precise control when navigating catheters and guidewires. For instance, in December 2023, Robocath S.A.S., a French MedTech firm, collaborated with Microport Medical B.V. from China and received approval from the National Medical Products Administration (NMPA) for their R-ONE vascular intervention surgical robot. This robot aids interventional cardiologists in performing accurate, minimally invasive procedures, such as percutaneous coronary interventions (PCI), by enhancing control, improving safety, and minimizing radiation exposure. The robot features advanced dual-finger grasp mimic technology, enabling continuous rotation from 0 to 360 degrees and providing precise, hand-like manipulation for complex vascular lesions. Moreover, it reduces radiation exposure for both patients and operators through optimized robotic navigation and less reliance on fluoroscopy.
In February 2025, Toulouse University Hospital (CHU), located in France, acquired the Epione robotic platform from Quantum Surgical SAS to advance minimally invasive cancer treatments. This acquisition is part of the hospital's commitment to enhancing precision in cancer care and improving patient outcomes using state-of-the-art robotic technology. Quantum Surgical SAS, a French medical robotics company, specializes in percutaneous puncture surgery robots.
Major companies operating in the percutaneous puncture surgery robot market are Intuitive Surgical Inc., Quantum Surgical SAS, iSYS Medizintechnik GmbH, Perfint Healthcare Private Limited, MicroPort Corporation, Robocath S.A.S., XACT Robotics Inc., NDR Medical Technology, Yuanhua Technology Co. Ltd., BEC Medical, Perlove Medical, Biobot Surgical Pte Ltd, Veran Medical Technologies Inc., Clear Guide Medical, Aimooe Technology Co. Ltd., Renishaw plc, Zimmer Biomet Holdings Inc., Perfexion Robotics, NeuroPuncture Systems, Synaptive Medical.
North America was the largest region in the percutaneous puncture surgery robot market in 2025. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the percutaneous puncture surgery robot market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the percutaneous puncture surgery robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the percutaneous puncture surgery robot market by raising import costs for robotic components, imaging systems, and ai software modules. Hospitals, ambulatory surgical centers, and specialized clinics in Europe, North America, and Asia-Pacific are most affected. Segments such as prostate and lung puncture robots, which rely heavily on imported precision components, face increased costs and adoption delays. Positive impacts include encouraging local assembly and software development, boosting innovation in cost-optimized robotic systems, and diversifying supply chains.
The percutaneous puncture surgery robot market research report is one of a series of new reports that provides percutaneous puncture surgery robot market statistics, including percutaneous puncture surgery robot industry global market size, regional shares, competitors with a percutaneous puncture surgery robot market share, detailed percutaneous puncture surgery robot market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous puncture surgery robot industry. This percutaneous puncture surgery robot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A percutaneous puncture surgery robot is a medical robotic system designed to assist surgeons in performing minimally invasive procedures by precisely guiding needles or instruments through the skin to target internal tissues or organs. These robots enhance surgical accuracy, reduce human error, and minimize patient trauma compared to traditional manual puncture techniques.
The primary types of percutaneous puncture surgery robots include prostate puncture robots, lung puncture robots, kidney puncture robots, and pancreas puncture robots. A prostate puncture robot is a specialized system that helps surgeons accurately guide needles or instruments for minimally invasive procedures, such as biopsies or therapies, within the prostate gland. Based on surgical approach, these robots are classified into robot-assisted percutaneous surgery and traditional percutaneous surgery. They integrate advanced technologies such as robotic-assisted navigation, augmented reality, and artificial intelligence and machine learning. Applications span multiple surgical fields, including orthopedic, cardiovascular, neurological, urological, and general surgery, serving end-users such as hospitals, ambulatory surgical centers, and specialized clinics.
The percutaneous puncture surgery robot market consists of revenues earned by entities by providing services such as surgical planning and simulation services, maintenance and technical support, remote surgery and teleoperation support, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous puncture surgery robot market also includes sales of robotic arm systems, 3D imaging and navigation systems, needle insertion modules, endoscopic camera systems, computer-aided planning software, and haptic feedback systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Percutaneous Puncture Surgery Robot Market Characteristics
3. Percutaneous Puncture Surgery Robot Market Supply Chain Analysis
4. Global Percutaneous Puncture Surgery Robot Market Trends and Strategies
5. Percutaneous Puncture Surgery Robot Market Analysis of End Use Industries
7. Global Percutaneous Puncture Surgery Robot Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Percutaneous Puncture Surgery Robot Total Addressable Market (TAM) Analysis for the Market
9. Percutaneous Puncture Surgery Robot Market Segmentation
10. Percutaneous Puncture Surgery Robot Market Regional and Country Analysis
11. Asia-Pacific Percutaneous Puncture Surgery Robot Market
12. China Percutaneous Puncture Surgery Robot Market
13. India Percutaneous Puncture Surgery Robot Market
14. Japan Percutaneous Puncture Surgery Robot Market
15. Australia Percutaneous Puncture Surgery Robot Market
16. Indonesia Percutaneous Puncture Surgery Robot Market
17. South Korea Percutaneous Puncture Surgery Robot Market
18. Taiwan Percutaneous Puncture Surgery Robot Market
19. South East Asia Percutaneous Puncture Surgery Robot Market
20. Western Europe Percutaneous Puncture Surgery Robot Market
21. UK Percutaneous Puncture Surgery Robot Market
22. Germany Percutaneous Puncture Surgery Robot Market
23. France Percutaneous Puncture Surgery Robot Market
24. Italy Percutaneous Puncture Surgery Robot Market
25. Spain Percutaneous Puncture Surgery Robot Market
26. Eastern Europe Percutaneous Puncture Surgery Robot Market
27. Russia Percutaneous Puncture Surgery Robot Market
28. North America Percutaneous Puncture Surgery Robot Market
29. USA Percutaneous Puncture Surgery Robot Market
30. Canada Percutaneous Puncture Surgery Robot Market
31. South America Percutaneous Puncture Surgery Robot Market
32. Brazil Percutaneous Puncture Surgery Robot Market
33. Middle East Percutaneous Puncture Surgery Robot Market
34. Africa Percutaneous Puncture Surgery Robot Market
36. Percutaneous Puncture Surgery Robot Market Competitive Landscape and Company Profiles
37. Percutaneous Puncture Surgery Robot Market Other Major and Innovative Companies
40. Percutaneous Puncture Surgery Robot Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Percutaneous Puncture Surgery Robot Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses percutaneous puncture surgery robot market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for percutaneous puncture surgery robot? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The percutaneous puncture surgery robot market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Prostate Puncture Robot; Lung Puncture Robot; Kidney Puncture Robot2) By Technology: Robotic Needle Guidance and Navigation; Artificial Intelligence-Enabled Target Planning; Motion Compensation and Respiratory Tracking; Image Fusion and 3D Targeting Software
3) By Clinical Application: Urology (Prostate Biopsy, Renal Procedures); Pulmonology (Lung Biopsy, Lung Ablation Access); Oncology (Tumor Biopsy and Localized Interventions); Interventional Radiology; Nephrology
4) By End User: Hospitals; Specialized Interventional Clinics; Diagnostic and Imaging Centers
Subsegments:
1) By Prostate Puncture Robot: Transperineal Prostate Puncture; Transrectal Prostate Puncture2) By Lung: Computed Tomography Guided Lung Puncture; Ultrasound Guided Lung Puncture
3) By Kidney: Percutaneous Nephrolithotomy Puncture; Renal Biopsy Puncture
Companies Mentioned: Intuitive Surgical Inc.; Quantum Surgical SAS; iSYS Medizintechnik GmbH; Perfint Healthcare Private Limited; MicroPort Corporation; Robocath S.A.S.; XACT Robotics Inc.; NDR Medical Technology; Yuanhua Technology Co. Ltd.; BEC Medical; Perlove Medical; Biobot Surgical Pte Ltd; Veran Medical Technologies Inc.; Clear Guide Medical; Aimooe Technology Co. Ltd.; Renishaw plc; Zimmer Biomet Holdings Inc.; Perfexion Robotics; NeuroPuncture Systems; Synaptive Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Percutaneous Puncture Surgery Robot market report include:- Intuitive Surgical Inc.
- Quantum Surgical SAS
- iSYS Medizintechnik GmbH
- Perfint Healthcare Private Limited
- MicroPort Corporation
- Robocath S.A.S.
- XACT Robotics Inc.
- NDR Medical Technology
- Yuanhua Technology Co. Ltd.
- BEC Medical
- Perlove Medical
- Biobot Surgical Pte Ltd
- Veran Medical Technologies Inc.
- Clear Guide Medical
- Aimooe Technology Co. Ltd.
- Renishaw plc
- Zimmer Biomet Holdings Inc.
- Perfexion Robotics
- NeuroPuncture Systems
- Synaptive Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.23 Billion |
| Forecasted Market Value ( USD | $ 3.54 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
